VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment
Status:
Completed
Trial end date:
2018-11-21
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label, PK and safety study of VNRX-5133 and VNRX-5022 when
co-administered in male and female subjects with varying levels of renal impairment and
healthy normal controls.